EPSTEIN BARR VIRUS INFECTION OF MUCOSAL EPITHELIUM
粘膜上皮的 Epstein Barr 病毒感染
基本信息
- 批准号:2094669
- 负责人:
- 金额:$ 15.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-05-01 至 1995-07-01
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte Epstein Barr virus antiviral antibody cell differentiation epithelium gene expression genetic manipulation genetic promoter element genetically modified animals laboratory mouse latent virus infection leukocyte activation /transformation molecular cloning nasopharyngeal neoplasms nucleic acid sequence oral leukoplakia oral mucosa polymerase chain reaction secretory immune system tissue /cell culture viral carcinogenesis virus DNA virus genetics virus infection mechanism virus replication
项目摘要
The long term goal of the proposed research is to identify virologic,
immunologic and cellular factors, unique to human mucosa, which contribute
to EBV persistence and to mechanisms of pathogenesis. EBV's disease
manifestations point to the importance of viral interactions in human
mucosa: nasopharyngeal carcinoma and oral hairy leukoplakia (characterized
by EBV latency and an aggressively replicative infection, respectively) are
epithelial diseases. African Burkitt's lymphoma, with its unusual tissue
distribution, is a malignancy of the mucosal-associated lymphoid tissue.
Because EBV's two tissue tropisms suggest that the virus may take advantage
of the close functional relations between epithelial and lymphoid elements
of the common mucosal immune system, we propose the following aims to reach
our long term goals: 1) Elucidation of the role of virus-specific IgA in
EBV pathogenesis; 2) examination of the role of cellular factors in the
regulation of the EBV life cycle in mucosal epithelium; 3) determination of
molecular and biological characteristics of EBV variants in the epithelial
tissue of oral hairy leukoplakia.
Polyclonal human IgA to EBV as well as IgA monoclonal antibodies to the
major glycoprotein of EBV (gp350) will be used to analyze "neutralization"
of EBV infectivity for lymphocytes and concurrent IgA-enhanced viral entry
into epithelial cells. The possibility of an immune-induced shift in EBV
tissue tropisms has tremendous implications for immunization strategy as
well as for general concepts of viral pathogenesis. The relation between
state of cell differentiation and viral gene expression will be analyzed,
first in epithelial tissues of transgenic mice by linking select EBV
promoters to beta galactosidase coding sequences; second, in diverse
populations of human B lymphocytes, by correlating markers of cell
activation/differentiation with virus gene expression. These experiments
will elucidate mechanisms of viral persistence and how virus may
disseminate after primary infection. Finally, the ability of defective
viral DNA to contribute to the high level of viral replication seen in
hairy leukoplakia will be examined, first by determination of its structure
with cloning and polymerase chain reaction analysis, then by use of novel
culture techniques to test its in vitro biologic activity. The existence
in nature of a defective virus particle with the ability to enhance, not
inhibit, replication of the parent strain suggests mechanisms by which a
persistent virus may move from latency to active replication.
这项拟议研究的长期目标是确定病毒学,
免疫和细胞因子,人类粘膜特有的,对
对EBV的持久性和发病机制进行了探讨。EB病毒病
症状表明病毒相互作用在人类中的重要性
粘膜:鼻咽癌和口腔毛状白斑(特征
分别由EBV潜伏期和侵袭性复制感染)是
上皮性疾病。非洲伯基特淋巴瘤及其不寻常的组织
分布,是一种恶性的粘膜相关淋巴组织。
因为EBV的两种组织趋向性表明该病毒可能利用
上皮细胞和淋巴系成分之间的密切功能关系
对于常见的粘膜免疫系统,我们提出了以下目标,以达到
我们的长期目标:1)阐明病毒特异性IgA在
EBV的发病机制;2)细胞因子在EB病毒感染中的作用
粘膜上皮中EB病毒生命周期的调节;3)测定
上皮细胞中EB病毒变异株的分子生物学特性
口腔毛状白斑组织。
抗EB病毒的多克隆人免疫球蛋白A以及抗EB病毒的人免疫球蛋白A单抗
EBV主要糖蛋白(Gp350)将用于分析“中和”
EB病毒对淋巴细胞的感染性和同时存在的IgA增强的病毒进入
转化为上皮细胞。EB病毒在免疫诱导下发生转变的可能性
组织趋向性对免疫策略具有巨大的影响,因为
以及病毒致病的一般概念。两者之间的关系
将分析细胞分化状态和病毒基因表达,
首次在转基因小鼠的上皮组织中通过连接特定的EBV
β半乳糖苷酶编码序列的启动子;第二,在不同的
通过细胞相关标志物检测人B淋巴细胞亚群
激活/分化与病毒基因表达有关。这些实验
将阐明病毒持续的机制以及病毒如何
在初次感染后传播。最后,有瑕疵的能力
病毒DNA有助于实现高水平的病毒复制
毛状白斑将首先通过确定其结构进行检查
通过克隆和聚合酶链式反应分析,然后使用新的
培养技术检测其体外生物活性。他的存在
在本质上有缺陷的病毒颗粒具有增强的能力,而不是
亲本菌株的抑制、复制提示了一种机制,即
持续病毒可能会从潜伏期转移到主动复制。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses.
Epstein-Barr 病毒编码的白细胞介素 10 同源物可增强病毒特异性细胞毒性 T 细胞和 HLA 非限制性杀伤细胞反应的重新激活。
- DOI:10.1016/0042-6822(92)90253-l
- 发表时间:1992
- 期刊:
- 影响因子:3.7
- 作者:Stewart,JP;Rooney,CM
- 通讯作者:Rooney,CM
Human oropharyngeal lesions with a defective Epstein-Barr virus that disrupts viral latency.
人类口咽部病变带有缺陷的 Epstein-Barr 病毒,可破坏病毒潜伏期。
- DOI:10.1093/infdis/168.6.1349
- 发表时间:1993
- 期刊:
- 影响因子:0
- 作者:Gan,YJ;Shirley,P;Zeng,Y;Sixbey,JW
- 通讯作者:Sixbey,JW
Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
原代 B 细胞肿瘤和 B 细胞系病毒和人白细胞介素 10 (IL-10) 的差异表达。
- DOI:10.1006/viro.1994.1236
- 发表时间:1994
- 期刊:
- 影响因子:3.7
- 作者:Stewart,JP;Behm,FG;Arrand,JR;Rooney,CM
- 通讯作者:Rooney,CM
Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.
- DOI:10.1126/science.1312750
- 发表时间:1992-03
- 期刊:
- 影响因子:56.9
- 作者:J. Sixbey;Q. Yao
- 通讯作者:J. Sixbey;Q. Yao
Epstein-Barr infection after bone marrow transplantation.
骨髓移植后 Epstein-Barr 感染。
- DOI:
- 发表时间:1994
- 期刊:
- 影响因子:20.3
- 作者:Heslop,HE;Li,C;Krance,RA;Loftin,SK;Rooney,CM
- 通讯作者:Rooney,CM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN W SIXBEY其他文献
JOHN W SIXBEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN W SIXBEY', 18)}}的其他基金
Epstein-Barr Virus-Enhanced Tumor Progression
Epstein-Barr 病毒增强的肿瘤进展
- 批准号:
7414860 - 财政年份:2006
- 资助金额:
$ 15.92万 - 项目类别:
Epstein-Barr Virus-Enhanced Tumor Progression
Epstein-Barr 病毒增强的肿瘤进展
- 批准号:
7247107 - 财政年份:2006
- 资助金额:
$ 15.92万 - 项目类别:
Epstein-Barr Virus-Enhanced Tumor Progression
Epstein-Barr 病毒增强的肿瘤进展
- 批准号:
7146318 - 财政年份:2006
- 资助金额:
$ 15.92万 - 项目类别:
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
- 批准号:
6176107 - 财政年份:1996
- 资助金额:
$ 15.92万 - 项目类别:
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
- 批准号:
2458673 - 财政年份:1996
- 资助金额:
$ 15.92万 - 项目类别:
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
- 批准号:
2897144 - 财政年份:1996
- 资助金额:
$ 15.92万 - 项目类别:
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
- 批准号:
2749379 - 财政年份:1996
- 资助金额:
$ 15.92万 - 项目类别:
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
- 批准号:
2015466 - 财政年份:1996
- 资助金额:
$ 15.92万 - 项目类别:
Epstein Barr Virus Induced Genomic Instability
EB 病毒引起的基因组不稳定
- 批准号:
6881605 - 财政年份:1995
- 资助金额:
$ 15.92万 - 项目类别:
EPSTEIN-BARR VIRUS INDUCED GENOMIC INSTABILITY
爱泼斯坦-巴尔病毒引起的基因组不稳定
- 批准号:
2330935 - 财政年份:1995
- 资助金额:
$ 15.92万 - 项目类别:
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
- 批准号:
489085 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
- 批准号:
10598376 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
- 批准号:
10910337 - 财政年份:2023
- 资助金额:
$ 15.92万 - 项目类别: